Evidence map›Paper›PMID 38337001›Full record

ArticleScientific reports2024

Correlations of SDF-1ɑ and XRCC1 gene polymorphisms with the risk of renal cancer development and bioinformatics studies of SDF-1α and XRCC1 and the prognosis of renal cancer.

Wenjing Zhang, Yubo Su, Genquan Yue, Lingyan Zhao, Hailing Li, Min Jia, Yuqi Wang, Dongyang Liu, Haisheng Wang, Yumin Gao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Wenjing ZhangSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Yubo SuSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Genquan YueDepartment of Urology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Lingyan ZhaoSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Hailing LiSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Min JiaSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Yuqi WangSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Dongyang LiuSchool of Public Health, Inner Mongolia Medical University, Hohhot, China.
Haisheng WangSchool of Public Health, Inner Mongolia Medical University, Hohhot, China. yxywhs001@126.com.
Yumin GaoSchool of Public Health, Inner Mongolia Medical University, Hohhot, China. gaoyumin0712@163.com.
Inner Mongolia Medical University · CN

Funding

Health Science and Technology Plan Project of Inner Mongolia Autonomous Region No.202201228
6 · The paper itself

Abstract

To study the relationships between stromal cell-derived factor-1 (SDF-1ɑ) and renal cell carcinoma (RCC) susceptibility and the presence of single nucleotide polymorphisms in the human X-ray cross-complementary repair gene (XRCC1). Compare SDF-1 based on RCC related data in the TCGA database α, The expression difference of XRCC1 between RCC tissue and normal tissue; Collect 166 newly diagnosed RCC cases and 166 healthy individuals who underwent physical examinations during the same period, and detect genotype using iMLDR method. The results The rs1801157 locus (C:T) of the SDF-1α gene was not significantly associated with the pathohistological type, the rs1799782 locus (G:A) of the XRCC1 gene was associated with the pathohistological type of RCC, and there were interactions between rs1799782 and smoking, alcohol consumption, pesticide exposure, hair dye, and urine holding. The rs1799782 locus of the XRCC1 gene may be a key factor in the pathogenesis and pathological development of RCC. High SDF-1ɑ expression is a protective factor for the overall survival of patients with RCC, and SDF-1ɑ and XRCC1 may be important for the treatment of RCC.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsCase-Control StudiesChemokine CXCL12Computational BiologyDNA-Binding ProteinsGenetic Predisposition to DiseaseGenotypeHumansPolymorphism, Single NucleotidePrognosisX-ray Repair Cross Complementing Protein 1Chemokine CXCL12DNA-Binding ProteinsX-ray Repair Cross Complementing Protein 1XRCC1 protein, humanBioinformatics analysisRCCSDF-1α geneSNPXRCC1 gene

Identifiers

PMID38337001
PMCPMC10858090
OpenAlexW4391678878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.